Table 3.
Variable | |
---|---|
Percutaneous renal tumor biopsy procedures (n = 84)† | |
Pathology, n (%) Benign Malignant Non-diagnostic |
14 (16.7) 53 (63.1) 17 (20.2) |
Samples’ diagnosis, n (%) Clear cell carcinoma Clear and papillary cell carcinoma Papillary carcinoma Colic adenocarcinoma Oncocytoma Chromophobe carcinoma Undefined carcinoma Angiomyolipoma Melanoma Lymphoma Myeloma |
30 (44.7) 1 (1.5) 9 (13.4) 2 (3.0) 10 (14.9) 3 (4.5) 3 (4.5) 4 (6.0) 1 (1.5) 3 (4.5) 1 (1.5) |
Tumor grade, n (%)‡ 1 2 4 |
18 (45.0) 20 (50.0) 2 (5.0) |
Patients undergoing renal surgery (n = 42) | |
Nephrectomy, n (%) Partial Total |
26 (61.9) 16 (38.1) |
Pathology, n (%) Benign Malignant |
0 (0.0) 42 (100) |
Histological diagnosis, n (%) Clear cell carcinoma Clear and papillary cell carcinoma Papillary carcinoma Colic adenocarcinoma Chromophobe carcinoma |
25 (59.5) 2 (4.8) 9 (21.4) 1 (2.4) 5 (11.9) |
Tumor grade, n (%)‡ 1 2 3 4 |
9 (25.0) 21 (58.3) 4 (11.1) 2 (5.6) |
n – number;
- repeated biopsies included;
- clear and papillary renal cell carcinoma